| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IVZ | Common Shares | Award | $0 | +211,864 | +47% | $0.000000 | 665,457 | 28 Feb 2022 | Direct | |
| transaction | IVZ | Common Shares | Award | $0 | +135,163 | +20% | $0.000000 | 800,620 | 28 Feb 2022 | Direct | |
| transaction | IVZ | Common Shares | Tax liability | $2,614,368 | -123,087 | -15% | $21.24 | 677,533 | 28 Feb 2022 | Direct | |
| transaction | IVZ | Common Shares | Sale | $3,701,203 | -189,708 | -28% | $19.51 | 487,825 | 01 Mar 2022 | Direct | F1 |
| holding | IVZ | Common Shares | 374,908 | 28 Feb 2022 | By GRAT | ||||||
| holding | IVZ | Common Shares | 3,199,053 | 28 Feb 2022 | By Trust | ||||||
| holding | IVZ | Common Shares | 519,507 | 28 Feb 2022 | By Trust | ||||||
| holding | IVZ | Common Shares | 400 | 28 Feb 2022 | By Spouse |
| Id | Content |
|---|---|
| F1 | Reflects the weighted-average purchase price. Common Shares were purchased in multiple transactions at prices ranging from $19.36 to $19.84 per share. The reporting person undertakes to provide upon request to the SEC staff, the issuer or its shareowners full information regarding the number of shares purchased at each separate price. |